Long-term intraocular pressure changes after femtosecond laser–assisted cataract surgery in healthy eyes and glaucomatous eyes

2019 ◽  
Vol 45 (2) ◽  
pp. 181-187 ◽  
Author(s):  
Avni A. Shah ◽  
Jeanie Ling ◽  
Niraj R. Nathan ◽  
Ashton J. Kalhorn ◽  
Qingxia Chen ◽  
...  
2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Chiara De Giacinto ◽  
Rossella D’Aloisio ◽  
Alessandro Bova ◽  
Tommaso Candian ◽  
Alberto Armando Perrotta ◽  
...  

Purpose. The aim of this retrospective cohort study was to evaluate intraocular pressure (IOP) changes during femtosecond laser-assisted cataract surgery (FLACS) using two different patient interface systems. Methods. 116 eyes of 116 patients scheduled for cataract surgery were divided into 2 groups: group 1 (61 eyes) and group 2 (55 eyes) underwent FLACS using Catalys Laser with fluid interface (liquid optics interface, LOI) and LenSx Laser with curved interface and soft contact lens (SoftFit), respectively. IOP was assessed using a portable rebound tonometer (Icare®) preoperatively, after docking, immediately after surgery, at one and seven days postoperatively. Results. In group 1, the mean IOP (±SD) was 14.1 ± 0.4 mmHg before surgery, 33.2 ± 1.1 mmHg after docking, and 21.4 ± 0.9 mmHg immediately after surgery. In group 2, the mean IOP was 13.8 ± 0.4 mmHg before surgery, 24.2 ± 1.4 mmHg after docking, and 20.2 ± 1.2 mmHg immediately after surgery. After the docking procedure, a statistically significant increase in IOP from the baseline was found in both groups (p<0.001). Moreover, no statistically significant difference in IOP measured at 1 and 7 days postoperatively was observed compared with the preoperative values (p>0.05) using both laser platforms. No intraoperative and postoperative complications were observed. Conclusions. FLACS suction phase resulted in a transient increase of IOP in both groups, especially with the LOI system, and it is probably related to the greater pressure of a suction ring and suction generated through the vacuum, independently from the effect of femtosecond laser itself.


2014 ◽  
Vol 252 (6) ◽  
pp. 1021-1021
Author(s):  
Masato Fujikawa ◽  
Osamu Sawada ◽  
Masashi Kakinoki ◽  
Tomoko Sawada ◽  
Hajime Kawamura ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Pei-Yao Chang ◽  
Jia-Kang Wang ◽  
Hsin-Yu Weng ◽  
Shu-Wen Chang

Abstract Cataract surgery leads to a sustained decrease in sitting intraocular pressure (IOP) in patients with angle-closure glaucoma (ACG). The purpose of this study is to evaluate whether cataract surgery can also reduce postural IOP changes. We prospectively examined 106 eyes from 53 patients with narrow angles scheduled for phacoemulsification. IOP was measured in the sitting, supine, and lateral decubitus positions using an ICare rebound tonometer before and 1 week, 1 month, and 3 months postoperatively. The mean baseline IOP in the sitting and lateral decubitus positions was 17.9 ± 4.8 mmHg and 21.43 ± 6.44 mmHg, which significantly reduced to 13.52 ± 3.8 and 17.46 ± 3.62, respectively, 3 month postoperatively (p < 0.001). However, postural IOP change (lateral decubitus minus sitting) at 3 months postoperatively was not significantly different from that at the baseline (3.17 ± 2.63 vs. 3.53 ± 3.38 mmHg, p = 0.85). Postural IOP change was not associated with preoperative sitting IOP, anterior chamber depth, axial length, fixed pupil, or presence of glaucomatous optic neuropathy. Patients with higher preoperative IOP exhibited greater IOP reduction after cataract surgery in every posture (p < 0.0001). In conclusion, cataract surgery reduces IOP in all postures among patients with ACG; however, it does not reduce the magnitude of postural IOP change.


2002 ◽  
Vol 28 (12) ◽  
pp. 2159-2164 ◽  
Author(s):  
Robert J. Casson ◽  
Claire E. Riddell ◽  
Rubina Rahman ◽  
Daniel Byles ◽  
John F. Salmon

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Julia Proença Pina ◽  
Khalil Turki ◽  
Julien Labreuche ◽  
Alain Duhamel ◽  
Thi Ha Chau Tran

Purpose. To evaluate the effects of repeated intravitreal dexamethasone implant (DI) (Ozurdex®) in eyes with macular edema (ME) due to retinal vein occlusion (RVO).Methods. Multicenter observational study including patients who received more than three consecutive DI on an “as-needed” basis for the treatment of ME in RVO.Results. A total of 18 eyes were included for analysis. Mean interval of retreatment with DI was 5.1 months between the first and second DI and 5.4 months following the second DI. Baseline BCVA was 0.74 ± 0.08 log-Mar; it significantly improved to 0.45 ± 0.04 2 months after the 3rd DI. There was no significant difference between the 3 first postinjection BCVA. CMT decreased from 617 μm ± 120 μm (baseline) to 330 ± 109 μm two months after the third DI. Elevated intraocular pressure occurred in 50% and was controlled medically. Cataract progression leading to cataract surgery occurred in 69% of phakic eyes after a mean interval of 17 months.Conclusion. Repeated DI on an “as-needed” basis, with a retreatment interval <6 months, are effective in the long term in the management of ME due to RVO. Rates of increased intraocular pressure and cataract surgery seem to be higher than previously described when eyes were followed during a longer period.


Sign in / Sign up

Export Citation Format

Share Document